U.S., Jan. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07359027) titled 'Study of Roxadustat's Effect on Anemia in Patients With Diabetic Kidney Disease' on Sept. 06, 2022.
Brief Summary: This study is a single-arm, open-label, multicenter and prospective study, which is conducted to evaluate the effect of Roxadustat on anemia in subjects with DKD (stage III-IV).
Study Start Date: Nov. 02, 2021
Study Type: INTERVENTIONAL
Condition:
Diabetic Kidney Disease
Anemia
Intervention:
DRUG: Roxadustat
The starting dose of Roxadustat will be defined as per the China Package Insert. The recommended starting dose of roxadustat will depend on the body weight of the patient (based on patient's empty weight prio...